Blackstone Inc’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Blackstone Inc’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,207	Closed	-$699K	–	196
2023 Q4	$699K	Buy	+2,207	New	+$429K	﹤0.01%	124

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Blackstone Inc's KRTX Position: Q1 2024 in Review

Blackstone Inc sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,207 shares — an estimated $699K sold.

Blackstone Inc first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $699K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Blackstone Inc reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Blackstone Inc sold 2,207 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $699K.
Blackstone Inc first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Blackstone Inc's Karuna Therapeutics, Inc. Common Stock position peaked at $699K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Blackstone Inc's 13F filing for Q1 2024, filed 15 May 2024.